FR2334366A2 - Application a titre d'agents antiviraux de composes d'heteropolyanions contenant du tungstene combine a de l'antimoine - Google Patents
Application a titre d'agents antiviraux de composes d'heteropolyanions contenant du tungstene combine a de l'antimoineInfo
- Publication number
- FR2334366A2 FR2334366A2 FR7605084A FR7605084A FR2334366A2 FR 2334366 A2 FR2334366 A2 FR 2334366A2 FR 7605084 A FR7605084 A FR 7605084A FR 7605084 A FR7605084 A FR 7605084A FR 2334366 A2 FR2334366 A2 FR 2334366A2
- Authority
- FR
- France
- Prior art keywords
- ammonium
- sodate
- tungsto
- antimonic
- pref
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 title abstract 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 title abstract 2
- 102000014150 Interferons Human genes 0.000 title abstract 2
- 108010050904 Interferons Proteins 0.000 title abstract 2
- 206010039491 Sarcoma Diseases 0.000 title abstract 2
- 229940079322 interferon Drugs 0.000 title abstract 2
- 208000032839 leukemia Diseases 0.000 title abstract 2
- 229910052751 metal Chemical class 0.000 title abstract 2
- 239000002184 metal Chemical class 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000003443 antiviral agent Substances 0.000 title 1
- 229940121357 antivirals Drugs 0.000 title 1
- 230000002195 synergetic effect Effects 0.000 title 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- 208000037273 Pathologic Processes Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 231100001222 nononcogenic Toxicity 0.000 abstract 1
- 150000004689 octahydrates Chemical class 0.000 abstract 1
- 230000009054 pathological process Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G41/00—Compounds of tungsten
- C01G41/006—Compounds containing tungsten, with or without oxygen or hydrogen, and containing two or more other elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/82—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/60—Optical properties, e.g. expressed in CIELAB-values
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB51415/76A GB1573002A (en) | 1975-12-10 | 1976-12-09 | Antiviral agent |
| JP14789976A JPS5294431A (en) | 1975-12-10 | 1976-12-10 | Antiivirus agent treatment for virus inffction and prevention method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63941375A | 1975-12-10 | 1975-12-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2334366A2 true FR2334366A2 (fr) | 1977-07-08 |
| FR2334366B2 FR2334366B2 (fr) | 1982-10-01 |
Family
ID=24563990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7605084A Granted FR2334366A2 (fr) | 1975-12-10 | 1976-02-24 | Application a titre d'agents antiviraux de composes d'heteropolyanions contenant du tungstene combine a de l'antimoine |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE848836R (fr) |
| DE (1) | DE2655690A1 (fr) |
| FR (1) | FR2334366A2 (fr) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0185584A1 (fr) * | 1984-12-03 | 1986-06-25 | Institut Pasteur | Utilisation de l'hétéropolyanion (NaSb9W21086)18- pour fabriquer une composition pharmaceutique destinée à être utilisée dans le traitement du sida et des syndromes analogues |
| FR2587214A1 (fr) * | 1985-09-13 | 1987-03-20 | Pasteur Institut | Anticoagulants constitues d'heteropolyanions tungstiques et utilisation de ces heteropolyanions a la preparation de medicaments anticoagulants |
| EP0690722A1 (fr) * | 1993-03-18 | 1996-01-10 | Cytimmune Sciences, Inc. | Composition et methode d'abaissement de la toxicite de facteurs biologiquement actifs |
| US6274552B1 (en) | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
| US6528051B2 (en) | 1997-11-10 | 2003-03-04 | Cytimmune Sciences, Inc. | Methods and compositions for enhancing immune response |
| US7229841B2 (en) | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990006756A1 (fr) * | 1988-12-16 | 1990-06-28 | Terumo Kabushiki Kaisha | Agent antiviral |
| US20010055581A1 (en) | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
| CN1925843A (zh) | 2003-12-02 | 2007-03-07 | 细胞免疫科学公司 | 生产单克隆抗体的方法和组合物 |
| CA2706700A1 (fr) | 2007-11-08 | 2009-05-14 | Cytimmune Sciences, Inc. | Compositions et procedes de production d'anticorps |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2245374B1 (fr) * | 1973-07-27 | 1977-02-25 | Anvar |
-
1976
- 1976-02-24 FR FR7605084A patent/FR2334366A2/fr active Granted
- 1976-11-26 BE BE172782A patent/BE848836R/fr not_active IP Right Cessation
- 1976-12-08 DE DE19762655690 patent/DE2655690A1/de active Granted
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0185584A1 (fr) * | 1984-12-03 | 1986-06-25 | Institut Pasteur | Utilisation de l'hétéropolyanion (NaSb9W21086)18- pour fabriquer une composition pharmaceutique destinée à être utilisée dans le traitement du sida et des syndromes analogues |
| DE3542165A1 (de) * | 1984-12-03 | 1986-07-10 | Centre National De La Recherche Scientifique (C.N.R.S.), Paris | Medikament zur behandlung des syndroms der erworbenen immunschwaeche (aids) und entsprechende pharmazeutische zusammensetzungen |
| FR2587214A1 (fr) * | 1985-09-13 | 1987-03-20 | Pasteur Institut | Anticoagulants constitues d'heteropolyanions tungstiques et utilisation de ces heteropolyanions a la preparation de medicaments anticoagulants |
| EP0690722A1 (fr) * | 1993-03-18 | 1996-01-10 | Cytimmune Sciences, Inc. | Composition et methode d'abaissement de la toxicite de facteurs biologiquement actifs |
| EP0690722A4 (fr) * | 1993-03-18 | 1997-08-06 | Cytimmune Sciences Inc | Composition et methode d'abaissement de la toxicite de facteurs biologiquement actifs |
| US6274552B1 (en) | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
| US6528051B2 (en) | 1997-11-10 | 2003-03-04 | Cytimmune Sciences, Inc. | Methods and compositions for enhancing immune response |
| US7387900B2 (en) | 1997-11-10 | 2008-06-17 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
| US7229841B2 (en) | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
Also Published As
| Publication number | Publication date |
|---|---|
| BE848836R (fr) | 1977-05-26 |
| DE2655690A1 (de) | 1977-06-23 |
| FR2334366B2 (fr) | 1982-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8700053A1 (es) | Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales | |
| FR2334366A2 (fr) | Application a titre d'agents antiviraux de composes d'heteropolyanions contenant du tungstene combine a de l'antimoine | |
| ES485068A1 (es) | Un procedimiento para preparar derivados de piridina o piri-midina | |
| JPS55373A (en) | Medicinal compound | |
| IE36716B1 (en) | Substituted cyclic urea derivatives and pharmaceutical compositions containing them | |
| ES455133A1 (es) | Un procedimiento de preparacion de 17-esteres de 17-alfa-hi-droxi-gestogenos. | |
| GB1490016A (en) | Amine salt of adenosine 5'-monophosphate having cardiovascular activity | |
| ES366470A1 (es) | Un procedimiento para la preparacion de pirazinoilgunidinasy pirazinomidoguanidinas. | |
| GB1465042A (en) | Catalysts for the manufacture of unsaturated nitriles | |
| BG47945A3 (en) | Method for preparing of organic zinc complexes | |
| GB967594A (en) | 2-(2,6-dimethyl-3-hydroxy-4-tert-butyl-benzyl)-2-imidazoline,and acid addition salts thereof,and process for their manufacture | |
| SE8802193D0 (sv) | Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of the same | |
| GB1491686A (en) | Process for purifying cyanogen chloride | |
| FR2100687A1 (en) | Lysozyme prepns - contng hydrogen peroxide and hydroxy-acids - or cysteine | |
| GB1329908A (en) | Pyridine derivatives | |
| GB1097338A (en) | Penicillanyl aldehydes | |
| GB1492006A (en) | Process for the production of maddrell's salt | |
| ES2005718A6 (es) | Un procedimiento para preparar una sal de alcanolamonio o una sal de amonio de un agente tesoactivo. | |
| ES8308335A1 (es) | Un procedimiento para la preparacion de nuevos derivados de desoxiuridina. | |
| GB1470747A (en) | Pyridazine derivative | |
| EP0158879A3 (en) | Compounds having cardiotrophic activity, a process for the preparation thereof and pharmaceutical compositions therefrom | |
| NL6900202A (en) | Antiviral and disinfectant compns contg alkylguanidine deri | |
| GB1466571A (en) | Substituted quinazolone compounds and pharmaceutical uses thereof | |
| FR2210388A1 (en) | 4-Phenoxy-3-hydroxy-butyramidines - as agents for treating cardiac rhythm disorders | |
| KR790000168B1 (en) | Salts of 2,6-dioxocyclohexane thiocarboxylic acid 4'-halo-anilides and pharmaceutical compositions |